Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -137.12% is 30% below its 5-year average of -105.08%, near the low end of its 5-year range (-174.32%–-24.09%).
8.49% below its 12-month average of -126.39%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -140.72%.
OPERATING MARGIN
-137.12%
OPERATING MARGIN AVG TTM
-126.39%
OPERATING MARGIN AVG 3Y
-128.03%
OPERATING MARGIN AVG 5Y
-105.08%
OPERATING MARGIN AVG 10Y
-80.32%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-8.49%
CURRENT VS 3Y AVG
-7.10%
CURRENT VS 5Y AVG
-30.49%
CURRENT VS 10Y AVG
-70.72%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
MaxCyte, Inc.
Market Cap
$114.08M
Operating Margin
-137.12%
TTM Avg
-126.39%
3Y Avg
-128.03%
5Y Avg
-105.08%
Market Cap
$114.14M
Operating Margin
-1054.82%
TTM Avg
-1057.23%
3Y Avg
-4752.68%
5Y Avg
-4082.42%
Market Cap
$113.89M
Operating Margin
-415175.00%
TTM Avg
-405687.50%
3Y Avg
-206404.23%
5Y Avg
-137602.82%
Market Cap
$114.91M
Operating Margin
-1220.49%
TTM Avg
-1443.83%
3Y Avg
-998.11%
5Y Avg
-830.42%
Market Cap
$113.07M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-1243.96%
5Y Avg
-829.31%
Market Cap
$112.61M
Operating Margin
-265.64%
TTM Avg
-359.98%
3Y Avg
-411.27%
5Y Avg
-4203.28%
Market Cap
$111.89M
Operating Margin
-754.08%
TTM Avg
-1999.61%
3Y Avg
-1887.55%
5Y Avg
-2072.97%
Market Cap
$117.28M
Operating Margin
-255.05%
TTM Avg
-370.20%
3Y Avg
-218.02%
5Y Avg
-145.34%
Market Cap
$109.91M
Operating Margin
-6.06%
TTM Avg
-25.69%
3Y Avg
-34.32%
5Y Avg
-39.92%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MaxCyte, Inc. (MXCT) | $114.08M | -137.12% | -126.39% | -128.03% | -105.08% |
| Lucid Diagnostics Inc. (LUCD)vs › | $114.14M | -1054.82% | -1057.23% | -4752.68% | -4082.42% |
| Genelux Corporation (GNLX)vs › | $113.89M | -415175.00% | -405687.50% | -206404.23% | -137602.82% |
| Caribou Biosciences, Inc. (CRBU)vs › | $114.91M | -1220.49% | -1443.83% | -998.11% | -830.42% |
| Unicycive Therapeutics, Inc. (UNCY)vs › | $113.07M | 0.00% | 0.00% | -1243.96% | -829.31% |
| Foghorn Therapeutics Inc. (FHTX)vs › | $112.61M | -265.64% | -359.98% | -411.27% | -4203.28% |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $111.89M | -754.08% | -1999.61% | -1887.55% | -2072.97% |
| Coya Therapeutics, Inc. (COYA)vs › | $117.28M | -255.05% | -370.20% | -218.02% | -145.34% |
| Apyx Medical Corporation (APYX)vs › | $109.91M | -6.06% | -25.69% | -34.32% | -39.92% |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $109.86M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
79.4%
Operating Margin
-137.1%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -140.72% |
| 2026-03-31 | -64.09% |
| 2025-12-31 | -105.10% |
| 2025-09-30 | -154.81% |
| 2025-06-30 | -167.24% |
| 2025-03-31 | -118.33% |
| 2024-12-31 | -148.41% |
| 2024-09-30 | -172.13% |
| 2024-06-30 | -114.76% |
| 2024-03-31 | -108.23% |
| 2023-12-31 | -51.68% |
| 2023-09-30 | -174.32% |
| 2023-06-30 | -144.56% |
| 2023-03-31 | -153.66% |
| 2022-12-31 | -54.33% |
| 2022-09-30 | -72.46% |
| 2022-06-30 | -90.96% |
| 2022-03-31 | -35.89% |
| 2021-12-31 | -48.81% |
| 2021-09-30 | -24.09% |
| 2021-06-30 | -62.14% |
| 2021-03-31 | -98.12% |
| 2020-12-31 | -27.97% |
| 2020-09-30 | -42.03% |
| 2020-06-30 | -55.23% |
| 2020-03-31 | -52.04% |
| 2019-12-31 | -26.13% |
| 2019-09-30 | -26.13% |
| 2019-06-30 | -106.99% |
| 2019-03-31 | -106.99% |
| 2018-12-31 | -40.46% |
| 2018-09-30 | -40.46% |
| 2018-06-30 | -64.72% |
| 2018-03-31 | -64.72% |
| 2017-12-31 | -68.25% |
| 2017-09-30 | -68.25% |
| 2017-06-30 | -64.17% |
| 2017-03-31 | -64.17% |
| 2016-12-31 | -25.99% |
| 2016-09-30 | -25.99% |
| 2016-06-30 | -17.48% |
| 2016-03-31 | -17.48% |
| 2015-12-31 | -3.39% |
| 2015-09-30 | -3.39% |
| 2015-06-30 | -14.02% |
| 2015-03-31 | -14.02% |
| 2014-12-31 | -8.50% |
| 2014-09-30 | -8.50% |
| 2014-06-30 | -31.03% |
| 2014-03-31 | -31.03% |
